During the COVID-19 pandemic in 2020, mortality risk for both COVID-19–positive and other patients on hemodialysis fluctuated in line with two waves of the pandemic in the general population.
During 4 waves of the COVID-19 pandemic in New York City, the risk of severe COVID-19 was associated with pre-existing chronic kidney disease, as well as heart disease, diabetes, and hypertension.
In clinical trials of patients with chronic kidney disease, combining information from the treatment effects on two markers of kidney disease progression—urinary albumin:creatinine ratio change and glomerular filtration rate slope—improves predictions of treatment effects on clinical endpoints.
Researchers have compared the impact of conservative management vs. dialysis on hospitalization outcomes in patients with advanced kidney disease across different races/ethnicities.
In a head-to-head comparison of two so-called ‘water pills’ that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.
Among US veterans with chronic kidney disease (CKD), Black individuals had a higher risk of developing kidney failure compared with White veterans, and their risk was more pronounced in the early years after kidney disease onset.
Among adults with normal kidney function, exposure to higher concentrations of components of air pollution was linked with higher risks of later developing chronic kidney disease.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person and online at ASN Kidney Week 2022 November 3–November 6.
Honor recognizes her dedication to effectively mentoring female cardiologists
Researchers have developed and validated an artificial intelligence–based algorithm to predict hospitalized patients’ risk of major adverse kidney events after discharge.
Investigators recently developed and validated an artificial intelligence–based model that can help clinicians predict which patients in the intensive care unit are most likely to develop acute kidney injury.
Scientists have generated a polygenic risk score for pediatric steroid sensitive nephrotic syndrome, a kidney disease in children.
In an analysis of data from the Framingham Heart Study, albuminuria (a marker of kidney disease) was associated with signs of silent stroke, and patients with albuminuria had a higher risk of developing mild cognitive impairment or dementia.
Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.
U.S. deaths from heart disease spiked in 2020 at the start of the COVID-19 pandemic after a steady decline from 2010 to 2019, reversing a public health success, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2022.
Invitation for emergency medicine symposium
The American Society of Anesthesiologists (ASA) today presented James D. Grant, M.D., MBA, FASA, with its 2021 Distinguished Service Award in recognition of his highly distinguished career as a physician anesthesiologist, enduring contributions to ASA members and deep commitment to advocating for the specialty and protecting patient safety.
American Society of Anesthesiologists names Michael W. Champeau, M.D., FASA, new president
In acknowledgment of her research advancing the field of cardiovascular science, UTHealth Houston’s Louise McCullough, MD, PhD, has been honored with the 2022 American Heart Association Basic Research Prize.
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone therapy improved progression-free survival (PFS) in patients with oligometastatic prostate cancer. Findings from the multicenter EXTEND trial were presented today at the 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right